Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients

BACKGROUND: Immune checkpoint inhibitors (ICIs) have become a high-profile regimen for malignancy recently. However, only a small subpopulation obtains long-term clinical benefit. How to select optimal patients by reasonable biomarkers remains a hot topic. METHODS: Paired tissue samples and blood sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qiao, Chen, Mingjing, Gu, Jiaoyang, Niu, Kai, Zhao, Xianlan, Zheng, Linpeng, Xu, Zihan, Yu, Yongxin, Li, Feng, Meng, Lingxin, Chen, Zhengtang, Zhuo, Wenlei, Zhang, Luping, Sun, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085403/
https://www.ncbi.nlm.nih.gov/pubmed/33936103
http://dx.doi.org/10.3389/fimmu.2021.665133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085403/
https://www.ncbi.nlm.nih.gov/pubmed/33936103
http://dx.doi.org/10.3389/fimmu.2021.665133

Ejemplares similares